Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Current Assets: 2014-2025

Historic Current Assets for AC Immune (ACIU) over the last 9 years, with Sep 2025 value amounting to $142.2 million.

  • AC Immune's Current Assets fell 34.33% to $142.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $142.2 million, marking a year-over-year decrease of 34.33%. This contributed to the annual value of $142.2 million for FY2025, which is N/A change from last year.
  • As of Q3 2025, AC Immune's Current Assets stood at $142.2 million, which was up 89,210.54% from $159,210 recorded in Q2 2025.
  • Over the past 5 years, AC Immune's Current Assets peaked at $243.9 billion during Q1 2021, and registered a low of $159,210 during Q2 2025.
  • Over the past 3 years, AC Immune's median Current Assets value was $125.9 million (recorded in 2024), while the average stood at $120.3 million.
  • In the last 5 years, AC Immune's Current Assets soared by 83,542.92% in 2021 and then plummeted by 99.93% in 2022.
  • AC Immune's Current Assets (Quarterly) stood at $219.8 million in 2021, then slumped by 39.49% to $133.0 million in 2022, then grew by 6.11% to $141.1 million in 2023, then tumbled by 99.86% to $196,335 in 2024, then crashed by 34.33% to $142.2 million in 2025.
  • Its Current Assets was $142.2 million in Q3 2025, compared to $159,210 in Q2 2025 and $169.2 million in Q1 2025.